Pmv Pharmaceuticals Inc (PMVP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $95.93M
Last updated: Nov 17, 2026 at 11:06 AM ET
Pmv Pharmaceuticals Inc (PMVP) Earnings: Report Dates and Results
Pmv Pharmaceuticals (PMVP) is expected to report earnings on Mar 4, 2027. In the quarter ended Sep 30, 2026, Pmv Pharmaceuticals reported EPS of -$0.29, below the -$0.28 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PMVP has an expected report date of Mar 4, 2027.
Earnings History
Of the 25 quarters below that had an estimate, PMVP beat 14, missed 10 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2024, when EPS landed 94.44% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.29 | -$0.28 | -$0.41 - -$0.25 | -3.57% | Miss | N/A | 2 | 1 up, 0 down | Nov 10, 2026 |
| Jun 30, 2026 | -$0.34 | -$0.38 | -$0.41 - -$0.38 | +10.53% | Beat | N/A | 3 | 1 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$0.34 | -$0.38 | -$0.41 - -$0.37 | +10.53% | Beat | N/A | 4 | 1 up, 0 down | May 12, 2026 |
| Dec 31, 2025 | -$0.34 | -$0.42 | N/A | +18.07% | Beat | N/A | 4 | 1 up, 0 down | Mar 6, 2026 |
| Sep 30, 2025 | -$0.40 | -$0.40 | -$0.43 - -$0.39 | 0.00% | In line | N/A | 4 | 2 up, 0 down | Nov 12, 2025 |
| Jun 30, 2025 | -$0.41 | -$0.39 | -$0.40 - -$0.37 | -5.13% | Miss | N/A | 4 | 2 up, 0 down | Aug 7, 2025 |
| Mar 31, 2025 | -$0.34 | -$0.38 | -$0.41 - -$0.37 | +10.53% | Beat | N/A | 3 | 1 up, 0 down | May 9, 2025 |
| Dec 31, 2024 | -$0.45 | -$0.38 | -$0.41 - -$0.33 | -18.42% | Miss | N/A | 3 | 2 up, 0 down | Mar 3, 2025 |
| Sep 30, 2024 | -$0.37 | -$0.36 | -$0.39 - -$0.32 | -2.78% | Miss | N/A | 7 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$0.02 | -$0.36 | -$0.41 - -$0.31 | +94.44% | Beat | N/A | 6 | 0 up, 0 down | Aug 8, 2024 |
| Mar 31, 2024 | -$0.30 | -$0.37 | -$0.46 - -$0.29 | +18.92% | Beat | N/A | 6 | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$0.31 | -$0.39 | -$0.43 - -$0.32 | +20.51% | Beat | N/A | 5 | 1 up, 0 down | Feb 29, 2024 |
| Sep 30, 2023 | -$0.34 | -$0.45 | -$0.46 - -$0.43 | +24.44% | Beat | N/A | 6 | 1 up, 0 down | Nov 9, 2023 |
| Jun 30, 2023 | -$0.38 | -$0.47 | -$0.50 - -$0.43 | +19.15% | Beat | N/A | 6 | 0 up, 0 down | Aug 9, 2023 |
| Mar 31, 2023 | -$0.42 | -$0.46 | -$0.49 - -$0.39 | +8.70% | Beat | N/A | 6 | 0 up, 0 down | May 10, 2023 |
| Dec 31, 2022 | -$0.43 | -$0.44 | -$0.45 - -$0.41 | +2.27% | Beat | N/A | 6 | 0 up, 0 down | Mar 1, 2023 |
| Sep 30, 2022 | -$0.40 | -$0.41 | -$0.44 - -$0.41 | +2.44% | Beat | N/A | 6 | 0 up, 0 down | Nov 8, 2022 |
| Jun 30, 2022 | -$0.38 | -$0.41 | N/A | +7.32% | Beat | N/A | N/A | 0 up, 0 down | Aug 9, 2022 |
| Mar 31, 2022 | -$0.41 | -$0.39 | -$0.45 - -$0.31 | -5.13% | Miss | N/A | 6 | 0 up, 0 down | May 10, 2022 |
| Dec 31, 2021 | -$0.40 | -$0.35 | -$0.37 - -$0.30 | -14.29% | Miss | N/A | 6 | N/A | Mar 1, 2022 |
| Sep 30, 2021 | -$0.33 | -$0.30 | -$0.33 - -$0.25 | -10.00% | Miss | N/A | 6 | N/A | Nov 12, 2021 |
| Jun 30, 2021 | -$0.29 | -$0.28 | -$0.30 - -$0.25 | -3.57% | Miss | N/A | 5 | N/A | Aug 13, 2021 |
| Mar 31, 2021 | -$0.26 | -$0.24 | -$0.28 - -$0.21 | -8.33% | Miss | N/A | 3 | N/A | May 14, 2021 |
| Dec 31, 2020 | -$0.63 | -$0.67 | N/A | +5.97% | Beat | N/A | N/A | N/A | Mar 3, 2021 |
| Sep 30, 2020 | -$0.65 | -$0.50 | -$0.50 - -$0.19 | -30.00% | Miss | N/A | 2 | N/A | Nov 13, 2020 |
| Jun 30, 2020 | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 25, 2020 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.49, after -$1.14 the year before. It was -$1.76 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.49 | N/A |
| Dec 31, 2024 | -$1.14 | N/A |
| Dec 31, 2023 | -$1.45 | N/A |
| Dec 31, 2022 | -$1.62 | N/A |
| Dec 31, 2021 | -$1.28 | N/A |
| Dec 31, 2020 | -$1.76 | N/A |
Frequently Asked Questions About PMVP
When is Pmv Pharmaceuticals's next earnings date?
Pmv Pharmaceuticals's next earnings report is expected for Mar 4, 2027.
Did PMVP beat earnings estimates last quarter?
No. Pmv Pharmaceuticals reported EPS of -$0.29 for the quarter ended Sep 30, 2026, below the -$0.28 estimate by 3.57%.
What EPS do analysts expect from PMVP next quarter?
The consensus EPS estimate for Pmv Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.26 from 6 analysts, with estimates from -$0.33 to -$0.19.
How often does PMVP beat earnings estimates?
Pmv Pharmaceuticals beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of +2.82%.
PMVP pages: Overview, Earnings, Forecast, Financials, Competitors